Cliantha Research Profile
Key Indicators
- Authorised Capital ₹ 10.50 Cr
- Paid Up Capital ₹ 3.78 Cr
- Company Age 20 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 125.00 Cr
- Satisfied Charges ₹ 9.25 Cr
- Revenue Growth 20.38%
- Profit Growth 14.46%
- Ebitda 13.29%
- Net Worth 10.28%
- Total Assets 15.26%
About Cliantha Research
Cliantha Research Limited (CRL) is a leading Public Limited Indian Non-Government Company incorporated in India on 30 August 2004 and has a history of 20 years and five months. Its registered office is in Ahmedabad, Gujarat, India.
The Corporate was formerly known as Ba Research India Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.50 Cr and a paid-up capital of Rs 3.78 Cr.
The company currently has active open charges totaling ₹125.00 Cr. The company has closed loans amounting to ₹9.25 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Cliantha Research Limited India is Naveen Sharma as CEO. Mukesh Patel, Manubhai Patel, Yogendra Gupta, and Two other members serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U73100GJ2004PLC044669
- Company No.
044669
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
30 Aug 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
What products or services does Cliantha Research Limited offer?
Cliantha Research Limited offers a wide range of products and services, including Graduation & High Education Programs, Medical Educational Service, Herbal & Ayurvedic Medical Services, Ayurvedic Treatment, Pharma & Bioanalytical Services, Pharmaceutical Services, Project Feasibility Studies, Market Research Service.
Who are the key members and board of directors at Cliantha Research?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Naveen Sharma | CEO | 03-Oct-2024 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mukesh Patel  | Director | 26-Sep-2008 | Current |
| Manubhai Patel | Director | 31-Mar-2017 | Current |
| Yogendra Gupta | Director | 07-Oct-2024 | Current |
| Nilima Kshirsagar | Director | 07-Oct-2024 | Current |
| Rajiv Kamani | Director | 07-Oct-2024 | Current |
Financial Performance of Cliantha Research.
Cliantha Research Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 20.38% increase. The company also saw a substantial improvement in profitability, with a 14.46% increase in profit. The company's net worth Soared by an impressive increase of 10.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cliantha Research?
In 2023, Cliantha Research had a promoter holding of 86.28% and a public holding of 13.72%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Desai Brothers LtdMukesh Patel is a mutual person
Epigral LimitedManubhai Patel is a mutual person
Gulmohar Greens-Golf And Country Club LimitedMukesh Patel is a mutual person
Foundation For Disease Elimination And Control Of IndiaYogendra Gupta is a mutual person
Desai Foods Private LimitedMukesh Patel is a mutual person
Bharat Immunologicals And Biologicals Corporation LimitedYogendra Gupta is a mutual person
Charges (Loans)
₹125.00 Cr
₹9.25 Cr
Charges Breakdown by Lending Institutions
- The Hongkong And Shanghai Banking Corporation Limited : 70.00 Cr
- Standard Chartered Bank : 55.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Aug 2018 | Standard Chartered Bank | ₹55.00 Cr | Open |
| 17 Oct 2017 | The Hongkong And Shanghai Banking Corporation Limited | ₹70.00 Cr | Open |
| 22 Jul 2020 | The Hongkong And Shanghai Banking Corporation Limited | ₹4.25 Cr | Satisfied |
| 29 May 2006 | Icici Bank Limited | ₹5.00 Cr | Satisfied |
How Many Employees Work at Cliantha Research?
Cliantha Research has a workforce of 1239 employees as of Nov 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cliantha Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cliantha Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
